PHIL, the technology-powered patient access platform designed to help patients get easy and affordable access to their prescribed medications, and Sprout Pharmaceuticals, today announced that they ...

Incregen Therapeutics Advances First-in-Class GIP Ligand Antagonist INC-118 into IND-Enabling Development to Address Long-Term Obesity Management INC-118 directly antagonizes the circulating Glucose ...

Semiconductor stocks enter 2026 with AI tailwinds but rising risks, narrow leadership, and Fed policy threats. Read here for ...

After the woman told a healthcare clinic she took abortion pills to end an unwanted pregnancy, authorities charged her under ...

Slomp Filho, M. (2026) Copyright in Generative Artificial Intelligence. Beijing Law Review, 17, 1-10. doi: ...